Children with severe enterovirus 71 infection

preprint OA: closed
View at publisher

Abstract

Background: There are few reports on the timing of onset and characteristics of the symptoms of enterovirus 71 (EV71) infection, which can easily be misjudged by clinicians. This study is aimed to explore the clinical characteristics of children with severe EV71 infection. Methods This retrospective observational study included children with severe EV71 infection who were admitted to Hebei Children’s Hospital between January 2016 and January 2018. Results A total of 101 patients were enrolled, with 57 males (56.4%) and 44 females (43.6%). They were 1–13 years of age. The symptoms were fever in 94 patients (93.1%), rash in 46 (45.5%), a susceptible mood in 70 (69.3%), and lethargy in 56 (55.4%). There were 19 (59.3%) cases with abnormal neurological magnetic resonance imaging [pontine tegmentum (n = 14, 43.8%), medulla oblongata (n = 11, 34.4%), midbrain (n = 9, 28.1%), cerebellum and dentate nucleus (n = 8, 25.0%), basal ganglia (n = 4, 12.5%), cortex (n = 4, 12.5%), spinal cord (n = 3, 9.3%), and meninges]. There was a positive correlation between the ratio of neutrophil count and white blood cell count in CSF in the first 3 days of the course of the disease (r = 0.415, P < 0.001). Conclusion The clinical symptoms of EV71 infection are fever and/or skin rash, easy convulsion, and lethargy. Some patients were with abnormal neurological magnetic resonance imaging. The white blood cell count in the cerebrospinal fluid of children with EV71 infection may increase with the ratio of peripheral blood neutrophils in the cerebrospinal fluid of children with EV71 infection.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00